Fig. 3

The number of WBCs was significantly reduced in rats after cyclophosphamide injection and increased after HPM treatment. A WBCs and their subtype percentage results. (n = 3–8 per each group). B–D RBC, hemoglobin and platelet counts (n = 8 per each group). Data were analyzed using One-way ANOVA tests with LSD-t post-hoc tests executed. ^*p < 0.05, ^**p < 0.01, ^***p < 0.001vs NG; ^#p < 0.05 vs CTX; ^%p < 0.05 vs HPM. ANOVA: analysis of variance; LSD-t: Least Significant Difference-t, NS: no significance; NG: normal group; CTX: cyclophosphamide; HPM: Herb-partitioned moxibustion; aCD28: anti-CD28; aCTLA-4: anti-CTLA-4; LEV: Levamisole